CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-01 | Mitchener Stephen SVP, Chief Business Officer | Sale | −6,357 | $3.03 | $19K | 128,313 |
| 2023-02-28 | Mitchener Stephen SVP, Chief Business Officer | Grant or award | +60,000 | 134,670 | ||
| 2022-08-31 | Mitchener Stephen SVP, Chief Business Officer | Grant or award | +20,000 | 70,546 | ||
| 2022-08-31 | Mitchener Stephen SVP, Chief Business Officer | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-02-28 | Mitchener Stephen SVP, Chief Business Officer | Grant or award | +47,250 | 50,546 | ||
| 2022-02-28 | Mitchener Stephen SVP, Chief Business Officer | Grant or award · Stock Option (right to buy) | +59,400 | 59,400 |
Page 1 of 1 · 6 trades